Working… Menu
Trial record 1 of 1 for:    ACE-1334
Previous Study | Return to List | Next Study

Study of ACE-1334 to Evaluate the Safety, Pharmacokinetics, Pharmacodynamic Effects, and Efficacy in Participants With Systemic Sclerosis With and Without Interstitial Lung Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04948554
Recruitment Status : Recruiting
First Posted : July 2, 2021
Last Update Posted : November 17, 2021
Information provided by (Responsible Party):
Acceleron Pharma Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2027
Estimated Study Completion Date : May 2028